Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass: A Randomized Controlled Trial (vol 114, pg 999, 2009)

被引：0
|
作者：
McClung, M.
Miller, P.
Recknor, C.
Messenbrink, P.
Bucci-Rechtweg, C.
Benhamou, C. -L.
机构：
来源：
OBSTETRICS AND GYNECOLOGY | 2010年 / 115卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1308 / 1308
页数：1
相关论文
共 50 条
  • [21] Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: A randomized controlled trial (vol 289, pg 2525, 2003)
    Greenspan, SL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (21): : 2798 - 2798
  • [22] Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: A randomized controlled trial (vol 289, pg 2525, 2003)
    Greenspan, S. L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (05): : 470 - 470
  • [23] Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial
    Jean Yves Reginster
    Dieter Felsenberg
    Imre Pavo
    Jan Stepan
    Juraj Payer
    Heinrich Resch
    Claus C. Glüer
    Dieter Mühlenbacher
    Deborah Quail
    Henry Schmitt
    Thomas Nickelsen
    Osteoporosis International, 2003, 14 : 741 - 749
  • [24] Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass:: a randomized, controlled trial
    Reginster, JY
    Felsenberg, D
    Pavo, I
    Stepan, J
    Payer, J
    Resch, H
    Glüer, CC
    Mühlenbacher, D
    Quail, D
    Schmitt, H
    Nickelsen, T
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 (09) : 741 - 749
  • [25] Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: A double-blind, randomized, controlled trial
    Chen, YM
    Ho, SC
    Lam, SSH
    Ho, SSS
    Woo, JLF
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10): : 4740 - 4747
  • [26] Durability and Delayed Treatment Effects of Zoledronic Acid on Bone Loss after Spinal Cord Injury: A Randomized, Controlled Trial (vol 36, pg 2127, 2021)
    Edwards, W. B.
    Haider, I. T.
    Simonian, N.
    Barroso, J.
    Schnitzer, T. J.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 (07) : 1043 - 1043
  • [27] Correspondence: "Effect of early treatment with zoledronic acid on prevention of bone loss in patients with acute spinal cord injury: a randomized controlled trial"
    Beaupre, Gary S.
    SPINAL CORD, 2018, 56 (12) : 1212 - 1212
  • [28] 1-YEAR CONTROLLED RANDOMIZED TRIAL OF PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS BY INTRANASAL CALCITONIN
    REGINSTER, JY
    ALBERT, A
    LECART, MP
    LAMBELIN, P
    DENIS, D
    DEROISY, R
    FONTAINE, MA
    FRANCHIMONT, P
    LANCET, 1987, 2 (8574): : 1481 - 1483
  • [29] Correspondence: “Effect of early treatment with zoledronic acid on prevention of bone loss in patients with acute spinal cord injury: a randomized controlled trial”
    Gary S. Beaupre
    Spinal Cord, 2018, 56 : 1212 - 1212
  • [30] The effects of progestins on bone density and bone metabolism in postmenopausal women: A randomized controlled trial - Discussion
    Lobo, RA
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 192 (04) : 1323 - 1324
12345